Skeletal muscle metabolic health is critical for mobility and an underrecognized target of metabolic acidosis in chronic kidney disease. Impaired muscle mitochondrial metabolism underlies poor physical endurance increasing the risk of mobility disability. The proposed project will use precise in vivo tools to study the pathophysiology of poor physical endurance in a clinical trial treating metabolic acidosis among persons living with chronic kidney disease.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
muscle mitochondrial oxidative capacity by 31P MRS
Timeframe: 16 weeks
Insulin sensitivity (SI) by insulin clamp
Timeframe: 16 weeks
total work performed on cycle ergometry VO2
Timeframe: 16 weeks
muscle work efficiency cycle ergometry
Timeframe: 16 weeks
Walking endurance by 6-minute walk
Timeframe: 16 weeks
FACIT-F Fatigue (PRO)
Timeframe: 16 weeks